Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
252
datasets available to search
ShareScore release 0.9.0
Dataset results
252 results for “Myasthenia”
Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT02473965. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
ClinicalTrials.gov study NCT00294658. IPD Sharing: YES. Countries: 18. Publications: 7.
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
ClinicalTrials.gov study NCT01997229. IPD Sharing: NO. Countries: 21. Publications: 10.
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT04124965. IPD Sharing: YES. Countries: 12. Publications: 2.
Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT02301624. IPD Sharing: Not stated. Countries: 17. Publications: 11.
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
ClinicalTrials.gov study NCT02110706. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT05218096. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT03772587. IPD Sharing: NO. Countries: 8. Publications: 1.
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
ClinicalTrials.gov study NCT03052751. IPD Sharing: Not stated. Countries: 7. Publications: 4.
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT04951622. IPD Sharing: YES. Countries: 17. Publications: 3.
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT04963270. IPD Sharing: Not stated. Countries: 17. Publications: 1.
ASV tables of Myasthenia gravis (MG) and non-Myasthenia gravis
Open the record for dataset details and reuse information.
Data from: Serum metabolomics predicts treatment response in myasthenia gravis
Open the record for dataset details and reuse information.
International consensus guidance for management of myasthenia gravis
<p>OBJECTIVE: To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature.</p> <p>METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to seven treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America. All prior recommendations were reviewed for currency, and new consensus recommendations were developed on topics that required inclusion or updates based on recent literature. Up to three rounds of anonymous e-mail votes were used to reach consensus, with modifications to recommendations between rounds based on panel input. A simple majority vote (80% of panel members voting 'yes') was used to approve minor changes in grammar and syntax to improve clarity.</p> <p>RESULTS: The previous recommendations for thymectomy were updated. New recommendations were developed for the use of rituximab, eculizumab and methotrexate as well as for the following topics: early immunosuppression in ocular MG and MG associated with immune checkpoint inhibitor treatment.</p> <p>CONCLUSION: This updated formal consensus guidance of international MG experts, based on new evidence, provides recommendations to clinicians caring for MG patients worldwide.</p>
Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis
ClinicalTrials.gov study NCT04158661. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization
ClinicalTrials.gov study NCT06624345. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis
ClinicalTrials.gov study NCT04302103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pyridostigmine and Amifampridine for Myasthenia Gravis
ClinicalTrials.gov study NCT05919407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
ClinicalTrials.gov study NCT07224386. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Seronegative Myasthenia Gravis - Efgartigimod IV
ClinicalTrials.gov study NCT06587867. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.